-
Study aim
-
Comparison of the effects of ethanol injection, radiofrequency ablation, levothyroxine therapy in the treatment of benign thyroid nodules based on nodule size changes in ultrasonography.
-
Design
-
Randomizes clinical trial with control group, parallel, single-blinded, on 91 patients through Block Randomization with blocks of 6.
-
Settings and conduct
-
In this multicenter study, after identifying the patient group, 31 patients underwent one-session radiofrequency ablation therapy, 30 patients underwent one session of 96% ethanol injection, and 30 patients underwent 6-month treatment with levothyroxine (standard dose 1.6-2.1 μg/kg/Per day), eventually this study will be single-blinded (data analyzer)
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria
Normal thyroid test TSH, T4, T3, T3RU, Anti TPO
History of pressure sign/nodule growth.
Benign biopsy specimen.
Normal blood calcitonin levels
The patient has not received previous treatment for thyroid nodules
Exclusion criteria:
Nodules with malignant features
Malignant or non-diagnostic pathology after biopsy under ultrasound guidance
Pregnancy
Abnormal thyroid function test or abnormal calcitonin
-
Intervention groups
-
Intervention medical treatment in form of suppression therapy with levothyroxine and intervention procedure with ethanol injection and radiofrequency ablation (RFA); levothyroxine treatment group is considered as control group and there is no placebo.
-
Main outcome variables
-
complications and efficacy of treatment with ethanol injection, radiofrequency ablation and levothyroxine therapy based on nodule size changes in ultrasound, gender, family history of thyroid cancer and changes in laboratory variables in the first, third and sixth months after treatment.